Biosense Webster shares latest data on its pulsed field ablation system
Cardiovascular Business,
Biosense Webster, part of Johnson
Biosense Webster, part of Johnson
February 14, 2023 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson
Late breaking analysis of one-year outcomes from the inspIRE clinical study demonstrated early success at the prespecified…
Late breaking analysis of one-year outcomes from the inspIRE clinical study demonstrated early success at the prespecified…